Medical News Today -
13 Dec 2013 18:00
New research suggests that patients with both hepatitis C and diabetes may have their cardiovascular and kidney outcomes improved with antiviral therapy. This is according to a study published in the journal Hepatology.Hepatitis C virus (HCV) is an infection that can infect and damage the liver. It can be contracted if a person comes into contact with infected blood or bodily fluids.According to the Centers for Disease Control and Prevention (CDC), HCV is the most common bloodborne infection in ...
Share this Article